EEF2K and neoplasm: YY1BM specifically binds to the transcription factor YY1, blocking its interaction with the androgen receptor (AR) and leading to the downregulation of eukaryotic elongation factor 2 kinase (eEF2K) expression in tumor cells through the AR signaling pathway.